JENAVALVE TECHNOLOGY

HQ - Irvine, CA

Summary

JenaValve is a medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of aortic regurgitation (AR).

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 608 M

Avg. Deal Size£ 304 M

Market Context

Senior Management

John Kilcoyne
CEO